| 2 | 110 | justify unaltered continuation pharm. | telce1 | 14.07.2009 | 12:28 |
| 1 | 126 | front line therapy pharm. | telce1 | 13.07.2009 | 17:33 |
| 2 | 94 | also had a case reported pharm. | telce1 | 13.07.2009 | 17:29 |
| 2 | 107 | European Union Annual Safety Report pharm. | telce1 | 13.07.2009 | 14:21 |
| 9 | 932 | executive summary pharm. | telce1 | 13.07.2009 | 13:54 |
| 1 | 73 | equivalent resistor med. | telce1 | 1.07.2009 | 22:35 |
| 2 | 94 | net filtration med. | telce1 | 1.07.2009 | 21:16 |
| 1 | 74 | exposed to pure med. | telce1 | 1.07.2009 | 19:41 |
| 7 | 124 | mercurial compound pharm. | telce1 | 12.06.2009 | 12:14 |
| 1 | 679 | potassium ethylparaben perf. | telce1 | 12.06.2009 | 11:38 |
| 5 | 224 | imaging follow-up med. | telce1 | 4.06.2009 | 7:41 |
| 2 | 139 | typical vascular pattern med. | telce1 | 4.06.2009 | 1:32 |
| 3 | 117 | at 3 month interval med. | telce1 | 4.06.2009 | 1:15 |
| 60 | transmittral doppler med. | telce1 | 24.05.2009 | 23:54 | |
| 2 | 113 | ICS, MCL, METS med. | telce1 | 24.05.2009 | 13:47 |
| 8 | 546 | sxs med. | telce1 | 24.05.2009 | 9:38 |
| 1 | 107 | systemic inquiry was noncontributory med. | telce1 | 23.05.2009 | 23:55 |
| 1 | 101 | genetlemen is a known med. | telce1 | 23.05.2009 | 17:37 |
| 7 | 3658 | Ethical Review Committees pharm. | telce1 | 21.05.2009 | 21:25 |
| 2 | 207 | confidential communication pharm. | telce1 | 18.05.2009 | 18:45 |
| 1 | 86 | Aerosol administration of interferon med. | telce1 | 12.05.2009 | 16:56 |
| 3 | 91 | the most commonly encountered med. | telce1 | 12.05.2009 | 16:26 |
| 2 | 146 | Segment I studies med. | telce1 | 2.05.2009 | 18:18 |
| 1 | 185 | AMENDMENT CHANGE med. | telce1 | 2.05.2009 | 12:49 |
| 1 | 192 | medium patient load med. | telce1 | 30.04.2009 | 18:01 |
| 1 | 81 | Standard Radiography Room med.appl. | telce1 | 29.04.2009 | 15:53 |
| 3 | 491 | well-established use application med. | telce1 | 19.04.2009 | 17:21 |
| 146 | boundary stat. | telce1 | 8.04.2009 | 19:02 | |
| 2 | 140 | stopping boundary pharm. | telce1 | 8.04.2009 | 17:02 |
| 52 | risk factor with 2 modalities stat. | telce1 | 7.04.2009 | 21:22 | |
| 1 | 100 | preference based measurement tool pharm. | telce1 | 7.04.2009 | 18:51 |